Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification

Addiction

Volumn 99, Issue 6, 2004, Pages 718-726

  Masson, Carmen L ^a,d   Barnett, Paul G ^a,b   Sees, Karen L ^a,c   Delucchi, Kevin L ^a   Rosen, Amy ^a   Wong, Wynnie ^a   Hall, Sharon M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Cost effectiveness; Health care; Injection drug use; Methadone detoxification; Methadone maintenance; Opiate use

Indexed keywords

METHADONE; OPIATE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG DEPENDENCE; DRUG DETOXIFICATION; DRUG USE; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ABUSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MENTAL HEALTH CARE; PATIENT EDUCATION; PROBABILITY; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; SUBSTANCE ABUSE; SURVIVAL;

ADULT; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; METABOLIC DETOXICATION, DRUG; METHADONE; NARCOTICS; OPIOID-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 2942588407     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2004.00728.x     Document Type: Article

References (32)

1. Barnett, P. G. (1999) The cost-effectiveness of methadone maintenance as a health care intervention. Addiction, 94, 479-488.
2. Barnett, P. G. & Hui, S. S. (2000) The cost-effectiveness of methadone maintenance. Mount Sinai Journal of Medicine, 67, 365-374.
3. Bradley, C. J., French, M. T. & Rachal, J. V. (1994) Financing and cost of standard and enhanced methadone treatment. Journal of Substance Abuse Treatment, 11, 433-442.
4. Doran, C. M., Shanahan, M., Mattick, R. P., Ali, R., White, J. & Bell, J. (2003) Buprenorphine versus methadone maintenance: a cost-effectiveness analysis. Drug and Alcohol Dependence, 71, 295-302.
5. Drummond, M., Torrance, G. & Mason, J. (1993) Cost-effectiveness league tables: more harm than good? Social Science and Medicine, 37, 33-40.
6. Freedberg, K. A., Scharfstein, J. A., Seage, G. R. III, Losina, E., Weinstein, M. C., Craven, D. E. & Paltiel, A. D. (1998) The cost-effectiveness of preventing AIDS-related opportunistic infections. Journal of the American Medical Association, 279, 130-136.
7. Garber, A. M., Weinstein, M. C., Torrance, G. W. & Kamlet, M. S. (1996) Theoretical foundations of cost-effectiveness analysis. In: Gold, M. R., Siegel, J. E., Russell, L. B. & Weinstein, M. C., eds. Cost-Effectiveness in Health and Medicine, pp. 25-53. New York: Oxford University Press.
8. Gerstein, D. R., Johnson, R. A., Harwood, H., Fountain, D., Suter, N. & Malloy, K. (1994) Evaluating Recovery Services: the California Drug and Alcohol Treatment Assessment (CALDATA), Sacramento, CA: California Department of Alcohol and Drug Programs.
9. Gold, M. R., Siegel, J. E., Russell, L. B. & Weinstein, M. C. (1996) Cost-Effectiveness in Health and Medicine. New York: Oxford University Press.
10. Hartz, D. T., Meek, P., Piotrowski, N. A., Tusel, D. A., Henke, C. J., Delucchi, K. L., Sees, K. L. & Hall, S. M. (1999) A cost-effectiveness and cost-benefit analysis of contingency contracting-enhanced methadone detoxification treatment. American Journal of Drug Alcohol Abuse, 25, 207-218.
11. Harwood, J. J., Hubbard, R. L., Collins, J. J. & Rachal, J. V. (1995) A cost-benefit analysis of drug abuse treatment. Research in Law and Policy Studies, 3, 191-214.
12. van Hout, B. A., Al, M. J., Gordon, G. S. & Rutten, F. F. (1994) Costs, effects and C/E-ratios alongside a clinical trial. Health Economics, 3, 309-319.
13. Kraft, M. K., Rothbard, A. B., Hadley, T. R., McLellan, A. T. & Asch, D. A. (1997) Are supplementary services provided during methadone maintenance really cost-effective? American Journal of Psychiatry, 154, 1214-1219.
14. Lavori, P. W., Dawson, R. & Shera, D. (1995) A multiple imputation strategy for clinical trials with truncation of patient data. Statistics in Medicine, 14, 1913-1925.
15. Liang, K. & Zeger, S. (1986) Longitudinal data analysis using generalized linear models. Biometrika, 73, 13-22.
16. Luce, B., Manning, W., Siegel, J. & Lipscomb, J. (1996) Estimating cost in cost-effectiveness analysis. In: Gold, M. R., Siegel, J. E., Russell, L. B. & Weinstein, M. C., eds. Cost-Effectiveness in Health and Medicine, pp. 25-53. New York: Oxford University Press.
17. Mann, A. R. & Feit, M. D. (1982-83) An analysis of federal narcotic detoxification policy: implications for rehabilitation. American Journal of Drug and Alcohol Abuse, 9, 289-299.
18. Marascuilo, L. A. & Serlin, R. C. (1988) Statistical Methods for the Social and Behavioral Sciences. New York: W.H. Freeman.
19. Mason, J., Drummond, M. & Torrance, G. (1993) Some guidelines on the use of cost effectiveness league tables. BMJ, 306, 570-572.
20. McCarty, D., Frank, R. G. & Denmead, G. C. (1999) Methadone maintenance and state Medicaid managed care programs. Milbank Quarterly, 77, 341-362.
21. McLellan, A. T., Arndt, I. O., Metzger, D. S., Woody, G. E. & O'Brien, C. P. (1993) The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association, 269, 1953-1959.
22. McLellan, A. T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., Pettinati, H. & Argeriou, M. (1992) The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment, 9, 199-213.
23. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction (1998) Effective medical treatment of opiate addiction. Journal of the American Medial Association, 280, 1936-1943.
24. O'Brien, B. J., Drummond, M. F., Labelle, R. J. & Willan, A. (1994) In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care. Medical Care, 32, 150-163.
25. Owens, D. K. (1998) Interpretation of cost-effectiveness analyses [Editorial]. Journal of General International Medicine, 13, 716-717.
26. Pinkerton, S. D., Holtgrave, D. R. & Bloom, F. R. (1998) Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. AIDS, 12, 1067-1078.
27. Reilly, P. M., Banys, P., Tusel, D. J., Sees, K. L., Krumenaker, C. L. & Shopshire, M. S. (1995) Methadone transition treatment: a treatment model for 180-day methadone detoxification. International Journal of the Addictions, 30, 387-402.
28. Rubin, D. B. & Schenker, N. (1991) Multiple imputation in health-care databases: an overview and some applications. Statistics in Medicine, 10, 585-598.
29. Sees, K. L., Delucchi, K. L., Masson, C. L., Rosen, A., Clark, H. W., Robillard, H., Banys, P. & Hall, S. M. (2000) Methadone maintenance vs. 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. Journal of the American Medical Association, 283, 1303-1310.
30. Sonnenberg, F. A. & Beck, J. R. (1993) Markov models in medical decision making: a practical guide. Medical Decision Making, 13, 322-338.
31. Sorensen, J. L., Hargreaves, W. A. & Weinberg, J. A. (1982) Withdrawal from heroin in three or six weeks: comparison of LAAM versus methadone. Archives of General Psychiatry, 39, 167-171.
32. Zaric, G. S., Barnett, P. G. & Brandeau, M. L. (2000) HIV transmission and the cost-effectiveness of methadone maintenance. American Journal of Public Health, 90, 1100-1111.